psychotropic drug
Showing 1 - 25 of >10,000
Impact of the Coronavirus Health Crisis on Psychotropic Drug Use
Not yet recruiting
- Psychotropic Drugs
- (no location specified)
Jun 3, 2022
Abuse and Addiction in ICU
Active, not recruiting
- Substance Withdrawal Syndrome
- AUDIT-C
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 18, 2021
Anticholinergic Burden On Daily Living Activities In Elderly
Not yet recruiting
- Anticholinergic Syndrome
- +5 more
- (no location specified)
Jun 13, 2023
Cognitive Symptom, Depression, Anxiety Trial in Grålum (Drug reviews with NorGeP-NH)
Completed
- Cognitive Symptom
- +7 more
- Drug reviews with NorGeP-NH
-
Grålum, NorwayØstfold Hospital Trust - Dept. of mental health
Feb 12, 2021
Schizophrenia and Disorders With Psychotic Features, Psychotic Episode Trial in Madrid (SocialMIND, Psychoeducational
Recruiting
- Schizophrenia and Disorders With Psychotic Features
- Psychotic Episode
- SocialMIND
- +3 more
-
Madrid, SpainLa Paz University Hospital
Aug 2, 2022
Anesthetics, Recovery, Drug Effect Trial in China (Remimazolam, Propofol group)
Not yet recruiting
- Anesthetics
- +5 more
- Remimazolam
- Propofol group
-
Lanzhou, Gansu, China
- +8 more
Jun 28, 2022
Drug Toxicity Psychotropic Agents Psychostimulants Trial in Baltimore (Ryanodex (dantrolene sodium) for injectable suspension)
Terminated
- Drug Toxicity Psychotropic Agents Psychostimulants
- Ryanodex (dantrolene sodium) for injectable suspension
-
Baltimore, MarylandCrowdRx Medical Office- Moonrise Festival
Mar 29, 2021
Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010; paliperidone palmitate, INVEGA SUSTENNA)
Active, not recruiting
- Schizophrenia
- +11 more
- LY03010; paliperidone palmitate
- INVEGA SUSTENNA
-
Garden Grove, California
- +8 more
Nov 19, 2021
Efficiency of E-learning and Role-playing for Training of
Completed
- Neuro-Degenerative Disease
- I-LEARN training
- usual care
-
Châteaugiron, France
- +6 more
Jan 26, 2023
Fall Related Injury Risk Trial in Montreal (CDS for psychotropic drug management)
Completed
- Fall Related Injury Risk
- CDS for psychotropic drug management
-
Montreal, Quebec, CanadaMcGill University
Aug 16, 2019
Genetic Evaluation for Medication Selection (GEMS) Study
Completed
- Dementia
- +2 more
- Delayed results of pharmacogenomic results
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Oct 3, 2019
COVID-19 Pandemic on Mental Health Service Utilization in
Recruiting
- Mental Disorder, Child
- national population-based study
-
Paris, FranceRobert Debre Hospital - Assistance Publique Hopitaux de Paris
Feb 28, 2022
Fall Trial (Blood sampling for psychoactive drugs dosage)
Not yet recruiting
- Fall
- Blood sampling for psychoactive drugs dosage
- (no location specified)
Aug 3, 2023
Deprescriptions, Antidepressive Agents, Antipsychotic Agents Trial in Bielefeld, Munich, Witten (PARTNER intervention, Control
Recruiting
- Deprescriptions
- +5 more
- PARTNER intervention
- Control intervention
-
Bielefeld, Germany
- +2 more
Apr 24, 2023
Maternal And Infant Antipsychotic Study
Not yet recruiting
- Antipsychotics
- Pregnancy
- Antipsychotics
- +2 more
- (no location specified)
Sep 16, 2023
Alzheimer, Dementia, Sleep Disorder Trial (LOCK Sleep Program, No intervention (control period/baseline data collection))
Not yet recruiting
- Alzheimer Disease
- +3 more
- LOCK Sleep Program
- No intervention (control period/baseline data collection)
- (no location specified)
Apr 7, 2023
Dementia, Deprescriptions, Antidepressive Agents Trial in Copenhagen (Teaching material, Pre-visit reflection tool, Dialogue
Active, not recruiting
- Dementia
- +3 more
- Teaching material
- +4 more
-
Copenhagen, DenmarkUniversity of Copenhagen, department of Public Health, section o
Feb 23, 2022
Patients With Schizophrenia Trial (Therapeutic Drug Monitoring (TDM) and Pharmacogenetics (PG))
Not yet recruiting
- Patients With Schizophrenia
- Therapeutic Drug Monitoring (TDM) and Pharmacogenetics (PG)
- (no location specified)
May 1, 2023
Acute Cannabinoid Intoxication Trial in Leiden (ANEB-001, Placebo)
Active, not recruiting
- Acute Cannabinoid Intoxication
- ANEB-001
- Placebo
-
Leiden, ZH, NetherlandsCentre for Human Drug Research (CHDR)
Jan 31, 2023
Alzheimer, Dementia, Sleep Disorder Trial in Tuscaloosa (LOCK sleep intervention)
Completed
- Alzheimer Disease
- +3 more
- LOCK sleep intervention
-
Tuscaloosa, AlabamaThe University of Alabama
Dec 21, 2022
Psychotic Disorders, Gastroesophageal Reflux Trial in Vancouver (Pantoprazole)
Withdrawn
- Psychotic Disorders
- Gastroesophageal Reflux
-
Vancouver, British Columbia, CanadaUBC Hospital - Detwiller Pavilion
Oct 1, 2021
Drug Resistance, Psychotropic Drugs Trial in Nice (gene abnormalities)
Completed
- Drug Resistance
- Psychotropic Drugs
- gene abnormalities
-
Nice, FranceFondation Lenval Hôpitaux Pédiatriques de Nice CHU-LENVAL
Feb 25, 2019
Pattern of Acute Antipsychotic Drug- Toxicity in Children
Not yet recruiting
- Antipsychotic Drug- Toxicity
- (no location specified)
Nov 6, 2023
Virtual Reality, Pediatrics, Cancer Trial in Poitiers (Virtual Reality, Usual Practices)
Recruiting
- Virtual Reality
- +4 more
- Virtual Reality
- Usual Practices
-
Poitiers, FranceCHU poitiers
Nov 30, 2022
MDD Trial in Salvador (Trial based cognitive therapy, Behavioral Activation, Antidepressants)
Completed
- Major Depressive Disorder
- Trial based cognitive therapy
- +2 more
-
Salvador, Bahia, BrazilCurt Hemanny
Mar 22, 2022